(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Other
Nov 17, 2009
0
0
(PhysOrg.com) -- Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published ...
Biochemistry
Nov 5, 2009
0
0
(PhysOrg.com) -- A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient?s own immune system ...
Biochemistry
Oct 23, 2009
0
0
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous ...
Biochemistry
Aug 6, 2009
0
0
A group of researchers at Johns Hopkins University has designed nanoparticles that can carry cancer-treating radioisotopes through the body and deliver them selectively to tumors. Today in Anaheim, CA, they will report the ...
Bio & Medicine
Jul 28, 2009
0
0
When cells experiencing DNA damage fail to repair themselves, they send a signal to their neighbors letting them know they're in trouble. The discovery, which shows that a process dubbed the DDR (DNA Damage Response) also ...
Cell & Microbiology
Jul 13, 2009
0
0
(PhysOrg.com) -- Researchers at the University of Rochester have developed a novel optical technique that permits rapid analysis of single human immune cells using only light.
Optics & Photonics
Apr 1, 2009
0
0
